Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (Q6)Dec 31, 2024 | (FY)Jun 30, 2024 | (Q6)Dec 31, 2023 | (FY)Jun 30, 2023 | (Q6)Dec 31, 2022 | (FY)Jun 30, 2022 | (Q6)Dec 31, 2021 | (FY)Jun 30, 2021 | (Q6)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -21.50%74.4M | -20.59%39.47M | -25.10%94.79M | -26.57%49.7M | -9.79%126.56M | -7.32%67.69M | 27.93%140.3M | 95.16%73.04M | 51.65%109.67M | -0.27%37.42M |
| Operating income | -21.50%74.4M | -20.59%39.47M | -25.10%94.79M | -26.57%49.7M | -9.79%126.56M | -7.32%67.69M | 27.93%140.3M | 95.16%73.04M | 51.65%109.67M | -0.27%37.42M |
| Operating expenses | ||||||||||
| Gross profit | ||||||||||
| Employee expense | -6.23%-27.64M | -17.34%-14.33M | 32.81%-26.02M | 8.94%-12.21M | 6.17%-38.72M | -6.42%-13.41M | -71.35%-41.27M | -7.60%-12.6M | -0.14%-24.08M | 7.19%-11.71M |
| Depreciation and amortization | 8.66%-9.26M | 2.52%-4.79M | -1.43%-10.14M | 13.89%-4.91M | -29.95%-9.99M | -131.08%-5.7M | -76.31%-7.69M | 10.22%-2.47M | 24.86%-4.36M | ---2.75M |
| Special items of operating profit | 25.36%-13.37M | 43.13%-6.53M | 0.48%-17.91M | -15.96%-11.49M | 1.00%-18M | 36.42%-9.91M | -141.13%-18.18M | -2,261.30%-15.58M | -19.23%-7.54M | 114.15%721K |
| Operating profit | -40.72%24.14M | -34.47%13.82M | -31.95%40.72M | -45.45%21.09M | -18.20%59.85M | -8.77%38.67M | -0.71%73.16M | 78.95%42.38M | 103.88%73.68M | 19.56%23.68M |
| Financing income | 20.64%1.58M | -5.61%808K | 68.98%1.31M | 3,790.91%856K | 1,366.04%777K | -64.52%22K | -40.45%53K | 40.91%62K | -91.51%89K | -92.20%44K |
| Financing cost | -17.36%-3.29M | -85.07%-1.72M | -44.05%-2.81M | -66.55%-931K | -151.35%-1.95M | -240.85%-559K | -279.90%-775K | -37.82%-164K | 37.42%-204K | ---119K |
| Share of profit from joint venture company | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 87.03%-89K | 113.38%57K |
| Earning before tax | -42.83%22.43M | -38.59%12.91M | -33.14%39.23M | -44.88%21.02M | -19.00%58.67M | -9.82%38.13M | -1.42%72.44M | 78.66%42.28M | 103.12%73.48M | 18.64%23.67M |
| Tax | 41.18%-4.89M | 28.13%-2.8M | 29.31%-8.31M | 48.43%-3.89M | 14.92%-11.76M | 14.10%-7.55M | -10.91%-13.82M | -121.98%-8.79M | -127.09%-12.46M | -29.51%-3.96M |
| After-tax profit from continuing operations | -43.27%17.54M | -40.97%10.11M | -34.10%30.92M | -44.01%17.12M | -19.96%46.92M | -8.69%30.58M | -3.94%58.62M | 69.95%33.49M | 98.83%61.02M | 16.67%19.71M |
| Earning after tax | -43.27%17.54M | -40.97%10.11M | -34.10%30.92M | -44.01%17.12M | -19.96%46.92M | -8.69%30.58M | -3.94%58.62M | 69.95%33.49M | 98.83%61.02M | 16.67%19.71M |
| Profit attributable to shareholders | -43.27%17.54M | -40.97%10.11M | -34.10%30.92M | -44.01%17.12M | -19.96%46.92M | -8.69%30.58M | -3.94%58.62M | 69.95%33.49M | 98.83%61.02M | 16.67%19.71M |
| Basic earnings per share | -43.34%0.0438 | -41.36%0.0251 | -34.10%0.0773 | -44.05%0.0428 | -19.99%0.1173 | -8.60%0.0765 | -3.93%0.1466 | 69.78%0.0837 | 98.96%0.1526 | 16.82%0.0493 |
| Diluted earnings per share | -43.47%0.0437 | -41.36%0.0251 | -34.10%0.0773 | -44.05%0.0428 | -19.99%0.1173 | -8.60%0.0765 | -3.93%0.1466 | 69.78%0.0837 | 98.96%0.1526 | 16.82%0.0493 |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
| Auditor | Guowei Certified Public Accountants Co., Ltd. | -- | Guowei Certified Public Accountants Co., Ltd. | -- | PwC Accounting Firm | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.